Development of a novel cancer immunotherapy based on tumor immunogenicity improvement by carbamazepine and HLA-B*15:02 interaction

○Shiyori SHUN

8:54 AM - 9:06 AM

[30-415-am03S] Development of a novel cancer immunotherapy based on tumor immunogenicity improvement by carbamazepine and HLA-B*15:02 interaction

○Shiyori SHUN^1,2, Takeshi Susukida¹, Tomohiro Shirayanagi³, Shigeki Aoki³, Kousei Ito³, Yoshihiro Hayakawa¹ (1. Institute of Natural Medicine, Univ of Toyama, 2. Grad School of Pharm Sci, Univ of Tokyo, 3. Grad School of Pharm Sci, Chiba Univ)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[30-415-am] Cancer

[30-415-am03S] Development of a novel cancer immunotherapy based on tumor immunogenicity improvement by carbamazepine and HLA-B*15:02 interaction

Password